Rinat Neuroscience

A leader in the development of therapeutic antibodies, spun out its key neuroscience assets under a broad license to Rinat.

Rinat, which means 'happiness' in Hebrew, was formed in 2001 when Genentech, a leader in the development of therapeutic antibodies, narrowed its focus and spun out its key neuroscience assets under a broad license to Rinat. Genentech invested significant R&D resources in support of these assets over 15 years, and Rinat is now building on them as the pioneer in developing and commercializing antibody drugs for the treatment of diseases and disorders of the nervous system.